Back
Grupo Aeroportuario del Centro Norte SAB de CV 10K Form
Buy
64
OMAB
Grupo Aeroportuario del Centro Norte SAB de CV
Last Price:
88.30
Seasonality Move:
3.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OMAB News And Ratings
See the #1 stock for the next 7 days that we like better than OMAB
OMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $593.23M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.17 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 4.09590 |
|---|---|
| Net Income (TTM): | $197.75M |
| Gross Margin: | $364.76M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Grupo Aeroportuario del Centro Norte SAB de CV Earnings Forecast
Key Grupo Aeroportuario del Centro Norte SAB de CV Financial Ratios
- The Gross Profit Margin over the past 18 years for OMAB is 61.49%.
- The Selling, General & Administrative Expenses for OMAB have been equal to 5.59% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 23.95% of Operating Income.
- The Net Earning history of OMAB is 32.69% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 12 years.
Grupo Aeroportuario del Centro Norte SAB de CV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Transportation Infrastructure |
| Sector: | Industrials |
| Current Symbol: | OMAB |
| CUSIP: | 400501 |
| Website: | oma.aero |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OMAB Technical Analysis vs Fundamental Analysis
Buy
64
Grupo Aeroportuario del Centro Norte SAB de CV (OMAB)
is a Buy
Is Grupo Aeroportuario del Centro Norte SAB de CV a Buy or a Sell?
-
Grupo Aeroportuario del Centro Norte SAB de CV stock is rated a Buy
The current Grupo Aeroportuario del Centro Norte SAB de CV [OMAB] share price is $88.12. The Score for OMAB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.